Adagene Inc.
ANTI-CD137 MOLECULES AND USE THEREOF
Last updated:
Abstract:
The present disclosure provides antibodies that bind to human CD137 or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, and for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
28 Dec 2021
Issue date:
30 Jun 2022